In recent months, federal and state lawmakers have been increasing their scrutiny of private equity’s role in healthcare consolidation and pricing. Policymakers are raising concerns about PE ownership structures they
Bayer is paying $300 million to buy Perfuse Therapeutics, a clinical-stage biotech that offers a new growth opportunity in ophthalmology as the pharmaceutical company’s top eye product weathers declining revenue
Health systems across the country will recognize their nursing staff for National Nurses Week on May 6-12, with everything from team lunches and awards to professional development opportunities. This year’s
Parsley Health, a functional medicine company, announced last week that it is now in-network with major insurance plans nationwide. As a virtual functional medicine provider, New York City-based Parsley Health
Tensions between providers and payers are increasingly spilling into the courtroom, with health systems and provider groups turning to the legal system for relief from what they say are unfair
Like a lot of clinicians, I worried about how the rise of AI might impact my field. I’m not opposed to innovation, but in healthcare, new tools have consequences when
Two North Carolina-based health systems, Atrium Health and WakeMed Health, announced plans to merge last week. As part of the proposed deal, Atrium plans to invest $2 billion into WakeMed
UCB is adding a big piece to its immunology pipeline with a multi-billion dollar deal to buy Candid Therapeutics, a clinical-stage biotech company developing therapies in a promising but competitive
Patient care may be the priority, but it’s only half the equation for healthcare facilities that also need to maintain financial organization and stability to support that care. So, why
Last summer, CVS and Mass General Brigham announced a deal they promised would expand access to primary care. Now, a state regulator is warning that not only is that outcome
